MedTrace Logo

Evaluate the Effect of Omega-3 vs Soy Isoflavones in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms

NCT02195609 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2016-09-16

No results posted yet for this study

Summary

This study is aiming to evaluate changes in vasomotor symptoms in postmenopausal women treated for 4 months with Omega-3 vs Soy Isoflavones.

Conditions

Interventions

DIETARY_SUPPLEMENT

Omega-3

600 mg oral twice a day

DIETARY_SUPPLEMENT

Soy Isoflavones

54.4 mg oral twice a day

Sponsors & Collaborators

  • Ferrer Internacional S.A.

    collaborator INDUSTRY

  • Instituto Palacios

    lead OTHER

Principal Investigators

  • Santiago Palacios, MD · President of the European Foundation Woman and Health,Past President and Honorary Member of the Spanish Menopause Society, President of the Council of Affiliated Menopause Societies (CAMS)

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2015-09-30
Completion
2015-11-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02195609 on ClinicalTrials.gov